Post-COVID-19 Spondylodiscitis: A Case Study and Review of the Literature

COVID-19 is currently a major health problem, leading to respiratory, cardiovascular and neurological complications, with additional morbidity and mortality. Spinal infections are rare, representing around 1% of all bone infections and comprising less than 2 per 10,000 of all hospitalizations in tertiary care centers. Spondylodiscitis is a complex disease, with challenging diagnosis and management. We report the case of a 45-year-old man, non-smoker hospitalized for severe COVID-19 disease with respiratory failure. Post-COVID-19, in the 8th week after discharge, he was diagnosed by magnetic resonance imaging with spondylodiscitis, but etiology was not confirmed by microbiological investigations. Antibiotics were used, considering the identification of MRSA from cultures of pleural fluid and nasal swab, but surgical intervention was not provided. Clinic, biologic and imagistic were improved, but rehabilitation and long term follow up are necessary. We concluded that spondylodiscitis with spinal abscess is a rare but severe complication post-COVID-19 disease, due to dysbalanced immune response related to the respiratory viral infection, endothelial lesions, hypercoagulation and bacterial superinfection.

[1]  Vinodharan Nagaretnam,et al.  A Case Series of Spinal Infections Following COVID-19: A Delayed Complication , 2022, Cureus.

[2]  A. Başak,et al.  A Combined Diagnosis and Treatment Algorithm for Spine Infection Management: A Single-Center Experience , 2022, Cureus.

[3]  Q. Ain,et al.  Pathophysiology of Methicillin-Resistant Staphylococcus aureus Superinfection in COVID-19 Patients , 2022, Pathophysiology : the official journal of the International Society for Pathophysiology.

[4]  R. M. Martínez Álvarez,et al.  Impacto de la bacteriemia por Staphylococcus aureus en pacientes con COVID-19 , 2022, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[5]  Gaurav Sharma,et al.  Case Report: Secondary Hemophagocytic Lymphohistiocytosis (sHLH) and Candida auris Fungemia in Post-acute COVID-19 Syndrome: A Clinical Challenge , 2022, Frontiers in Medicine.

[6]  E. Molloy,et al.  Neutrophils in COVID-19: Not Innocent Bystanders , 2022, Frontiers in Immunology.

[7]  B. Purandare,et al.  COVID-19 Associated Vertebral Osteomyelitis Caused by Aspergillus Species—A Case Series , 2022, Indian Journal of Orthopaedics.

[8]  D. Yahav,et al.  ESCMID rapid guidelines for assessment and management of long COVID , 2022, Clinical Microbiology and Infection.

[9]  S. Dudli,et al.  Intervertebral disc cell chondroptosis elicits neutrophil response in Staphylococcus aureus spondylodiscitis , 2022, bioRxiv.

[10]  K. Kıbıcı,et al.  COVID-19 Infection Manifesting with Lumbar Spondylodiscitis Complicating With Psoas Abscess without Pneumonia , 2021, Indian Journal of Neurosurgery.

[11]  I. Paredes,et al.  Case Report: SARS-CoV-2 Infection—Are We Redeemed? A Report of Candida Spondylodiscitis as a Late Complication , 2021, Frontiers in Medicine.

[12]  Gabriela Lupășteanu,et al.  Epidemiologic and Clinic Characteristics of the First Wave of the COVID-19 Pandemic in Hospitalized Patients from Galați County , 2021, Journal of clinical medicine.

[13]  C. Nimsky,et al.  Neurosurgical Management and Outcome Parameters in 237 Patients with Spondylodiscitis , 2021, Brain sciences.

[14]  D. Kempen,et al.  Long-term Quality of Life outcome after spondylodiscitis treatment. , 2021, The spine journal : official journal of the North American Spine Society.

[15]  G. Umana,et al.  Spontaneous anterior cervicothoracic spinal epidural hematoma extending to clivus in SARS-CoV-2 infection , 2021, Surgical neurology international.

[16]  Paul J. Harrison,et al.  6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records , 2021, The Lancet Psychiatry.

[17]  D. Kendoff,et al.  Serum C-reactive protein and WBC count in conservatively and operatively managed bacterial spondylodiscitis , 2021, Journal of orthopaedic surgery.

[18]  C. June,et al.  Cytokine Storm , 2020, The New England journal of medicine.

[19]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[20]  Z. Sharfman,et al.  Spinal Epidural Abscess: A Review of Presentation, Management, and Medicolegal Implications , 2020, Asian spine journal.

[21]  D. Hänggi,et al.  COVID-19 Infection Leading to Lethal Spondylodiscitis with Spinal Abscess , 2020 .

[22]  M. Cenzato,et al.  Spinal epidural abscess in COVID-19 patients , 2020, Journal of Neurology.

[23]  Andrea Gianatti,et al.  Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study , 2020, The Lancet Infectious Diseases.

[24]  Yuhao Zhang,et al.  New understanding of the damage of SARS-CoV-2 infection outside the respiratory system , 2020, Biomedicine & Pharmacotherapy.

[25]  Nils Kucher,et al.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.

[26]  Hong Jiang,et al.  Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up , 2020, Journal of Infection.

[27]  M. Muto,et al.  Joint EANM/ESNR and ESCMID-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  G. Hofmann,et al.  SponDT (Spondylodiscitis Diagnosis and Treatment): spondylodiscitis scoring system , 2019, Journal of Orthopaedic Surgery and Research.

[29]  S. Liang,et al.  Musculoskeletal Infections in the Emergency Department. , 2018, Emergency medicine clinics of North America.

[30]  F. Certo,et al.  Management of spinal infection: a review of the literature , 2018, Acta Neurochirurgica.

[31]  M. Breuninger,et al.  Spondylodiscitis: Diagnosis and Treatment Options. , 2017, Deutsches Arzteblatt international.

[32]  Panayiotis D. Megaloikonomos,et al.  Spondylodiscitis revisited , 2017, EFORT open reviews.

[33]  B. Kitov,et al.  Spontaneous Spondylodiscitis - Epidemiology, Clinical Features, Diagnosis and Treatment , 2017, Folia medica.

[34]  K. Tsang,et al.  Management of adult spontaneous spondylodiscitis and its rising incidence. , 2015, Annals of the Royal College of Surgeons of England.

[35]  A. Fattah,et al.  Management of Patients with Spondylodiscitis: An Overview , 2021 .

[36]  China Cdc Weekly The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 , 2020, China CDC weekly.

[37]  A. Mavrogenis,et al.  Spinal Infections: An Update , 2020, Microorganisms.

[38]  R. Evans European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).